Self-reported health-related quality of life in persons with HIV infection: Results from a multi-site interview project

被引：85

作者：

Michael L Campsmith

Allyn K Nakashima

Arthur J Davidson

机构：

[1] Division of HIV/AIDS Prevention, Natl. Ctr. for HIV STD/TB Prevention, Centers for Dis. Control/Prevention, Atlanta, GA

[2] Denver Department of Public Health, Denver, CO

来源：

Health and Quality of Life Outcomes | / 1卷 / 1期

关键词：

Antiretroviral therapy; HIV/AIDS; Quality of life;

D O I：

10.1186/1477-7525-1-12

中图分类号：

学科分类号：

摘要：

Background: To examine demographic and behavioral associations with self-reported health-related quality of life (HRQOL) among persons with HIV infection or AIDS. Methods: Analysis of interviews with persons ≥ 18 years of age reported through routine disease surveillance with HIV infection or AIDS to nine state and local health departments from January 1995 through December 1996. Scales were constructed from validated measures of HRQOL, and mean scores were calculated (lower scores signified poorer HRQOL). Measures of HRQOL included Overall Health, Pain, Physical Functioning, Role Functioning, Social Functioning, Mental Health, Energy/Fatigue, and Cognitive Functioning. Differences in HRQOL were examined by various demographic and behavioral factors, including taking antiretroviral medication. Results: HRQOL data were available for 3778 persons. Factors associated with lower HRQOL scores included older age, female sex, black or Hispanic race/ethnicity, injection drug use, lower education and income, no private health insurance, and lower CD4 count. In multivariate analysis, lower CD4 count was the factor most consistently associated with lower HRQOL. Taking antiretroviral medication was not associated with differences in HRQOL regardless of CD4 count. Conclusions: Perception of HRQOL varied in a population with HIV infection or AIDS. On most HRQOL measures, lower CD4 count was associated with lower HRQOL. Measurement of HRQOL can assist in understanding the long-term effects of disease and treatment on persons with HIV. © 2003 Campsmith et al; licensee BioMed Central Ltd.

引用

页数：6

共 32 条

[1]

Carpenter C.C., Fischl M.A., Hammer S.M., Antiretroviral therapy for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA Panel, JAMA, 280, pp. 78-86, (1998)

[2]

Deeks S.G., Smith M., Holodniy M., Kahn J.O., HIV-1 protease inhibitors. A review for clinicians, JAMA, 277, pp. 145-153, (1997)

[3]

Saag M.S., Schooley R.T., Antiretroviral chemotharapy, Current Clinical Topics Infectious Diseases, 18, pp. 154-179, (1998)

[4]

HIV/AIDS Surveillance Report, 12, 2, pp. 38-39, (2000)

[5]

Guidelines for the using antiretroviral agents among HIV-infected adults and adolescents recommendations of the Panel on Clinical Practices for Treatment of HIV, MMWR, 51, pp. 5-12, (2002)

[6]

Lalonde L., Clarke A.E., Joseph L., Mackenzie T., Grover S.A., Health-related quality of life with coronary heart disease prevention and treatment, J. Clinical Epidemiology, 54, pp. 1011-1018, (2001)

[7]

Janz N.K., Janevic M.R., Dodge J.A., Factors influencing quality of life in older women with heart disease, Medical Care, 39, pp. 588-598, (2001)

[8]

Strand V., Tugwell P., Bombardier C., Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis, Arthritis and Rheumatism, 42, pp. 1870-1878, (1999)

[9]

Gregg E.W., Beckles G.L., Williamson D.F., Diabetes and physical disability among older U.S. adults, Diabetes Care, 23, pp. 1272-1277, (2000)

[10]

Rapp S.R., Feldman S.R., Exum M.L., Fleisher Jr. A.B., Reboussin D.M., Psoriasis causes as much disability as other major medical diseases, Journal American Academy Dermatology, 41, pp. 401-407, (1999)

← 1 2 3 4 →